Development of antigen detection kits for the diagnosis of leishmaniasis

Projektinformationen

NEW KATEX

ID Finanzhilfevereinbarung: QLK2-CT-2001-60087

Startdatum 10 Februar 2003

Enddatum 9 Februar 2007

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 84 672,00

EU-Beitrag € 84 672,00

Koordiniert durch

KALON BIOLOGICAL LTD
United Kingdom

Ziel

Design and development of antigen capture test (in ELISA and lateral flow format) for the immunodiagnosis of human and canine visceral leishmaniasis.

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-2. - Key action Control of Infectious Diseases

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

BUR - Bursaries, grants, fellowships

Koordinator

KALON BIOLOGICAL LTD

• EU-Beitrag: Keine Daten
• Adresse: Unit 8 Enterprise State Station Road West ; GU12 5QJ ALDERSHOT - HAMSHIRE ; Vereinigtes Königreich
• Gesamtkosten: Keine Daten